2 Articles by Yasmin Schmid
Motivation and retrospective appraisal of psychedelic study participation: a qualitative study in healthy volunteers.
Psychopharmacology – March 26, 2025
Summary
Healthy volunteers are increasingly drawn to participate in psychedelic trials, motivated by personal growth and the allure of substances like psilocybin, Dimethyltryptamine, Lysergic acid diethylamide, and mescaline. Participants reported positive appraisals linked to supportive relationships with researchers and immersive environments. Most felt their experiences surpassed expectations and expressed a desire for future sessions in nature with friends, highlighting the importance of setting and interpersonal connections in enhancing the psychedelic experience.
Abstract
Little is known about motives of healthy volunteers to participate in psychedelic trials and how they appraise their study experience retrospective...
Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults: A Randomized Clinical Trial.
JAMA psychiatry – March 19, 2025
Summary
Microdosing with LSD shows promise for ADHD treatment, yet this study found it no more effective than a placebo. Over six weeks, adults receiving low doses of LSD reported similar symptom improvements as those on placebo. While safe and well-tolerated, LSD didn't outperform standard treatments in alleviating ADHD symptoms.
Abstract
Microdosing psychedelics, including lysergic acid diethylamide (LSD), has gained attention for its potential benefits in several psychiatric disord...